142 related articles for article (PubMed ID: 2889222)
1. Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase.
Abbracchio MP; Colombo F; Di Luca M; Zaratin P; Cattabeni F
Pharmacol Res Commun; 1987 Apr; 19(4):275-86. PubMed ID: 2889222
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptors in canine caudate nucleus.
Maeno H
Mol Cell Biochem; 1982 Mar; 43(2):65-80. PubMed ID: 6123940
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
[TBL] [Abstract][Full Text] [Related]
4. Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics.
Memo M; Battaini F; Spano PF; Trabucchi M
Acta Psychiatr Scand; 1981 Apr; 63(4):314-24. PubMed ID: 7315480
[TBL] [Abstract][Full Text] [Related]
5. Role of phospholipids in coupling of adenosine and dopamine receptors to striatal adenylate cyclase.
Anand-Srivastava MB; Johnson RA
J Neurochem; 1981 May; 36(5):1819-28. PubMed ID: 6264036
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
Murayama T; Itahashi Y; Nomura Y
J Neurochem; 1990 Nov; 55(5):1631-8. PubMed ID: 2145396
[TBL] [Abstract][Full Text] [Related]
7. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
8. Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice.
Olianas MC; Onali P
Neurosci Lett; 1987 Aug; 78(3):349-54. PubMed ID: 2819791
[TBL] [Abstract][Full Text] [Related]
9. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
Memo M; Pizzi M; Missale C; Carruba MO; Spano PF
Neuropharmacology; 1987 May; 26(5):477-80. PubMed ID: 2955241
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
11. Increased sensitivity of adenylate cyclase activity in the striatum of the rat to calmodulin and GppNHp after chronic treatment with haloperidol.
Treisman GJ; Muirhead N; Gnegy ME
Neuropharmacology; 1986 Jun; 25(6):587-95. PubMed ID: 3092124
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor changes in response to prolonged treatment with L-dopa.
Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
[TBL] [Abstract][Full Text] [Related]
13. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
[TBL] [Abstract][Full Text] [Related]
14. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
Porceddu ML; Giorgi O; De Montis G; Mele S; Cocco L; Ongini E; Biggio G
Life Sci; 1987 Aug; 41(6):697-706. PubMed ID: 2956472
[TBL] [Abstract][Full Text] [Related]
15. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
O'Shaughnessy CT; Headley PM
Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
[TBL] [Abstract][Full Text] [Related]
16. Regulation of adenosine-sensitive adenylate cyclase from rat brain striatum.
Anand-Srivastava MB; Johnson RA
J Neurochem; 1980 Oct; 35(4):905-14. PubMed ID: 6161233
[TBL] [Abstract][Full Text] [Related]
17. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
18. Dopamine-sensitive adenylate cyclase: location in substantia nigra.
Gale K; Guidotti A; Costa E
Science; 1977 Feb; 195(4277):503-5. PubMed ID: 13499
[TBL] [Abstract][Full Text] [Related]
19. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
[TBL] [Abstract][Full Text] [Related]
20. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
